Boston Scientific SEC filings, summarized
We read every Boston Scientific 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track BSX in your inbox
Add Boston Scientific to your watchlist — free, every morning.
Recent filings
8‑K (Item 9.01): Boston Scientific ($BSX) on Feb 26, 2026 filed three credit agreements — two Credit…
8‑K (Item 9.01): Boston Scientific ($BSX) on Feb 26, 2026 filed three credit agreements — two Credit Agreements (Exs. 10.1 & 10.2) and a Term Loan Credit…
Boston Scientific ($BSX) 8-K filed 2026-02-26: Item 2.03 confirms creation of a direct financial…
Boston Scientific ($BSX) 8-K filed 2026-02-26: Item 2.03 confirms creation of a direct financial obligation / off‑balance‑sheet arrangement via the 2026…
Boston Scientific ($BSX) terminated its prior 2021 Revolving Credit Agreement on Feb 26, 2026 after…
Boston Scientific ($BSX) terminated its prior 2021 Revolving Credit Agreement on Feb 26, 2026 after entering a new 2026 Revolving Credit Agreement. Prior…
BREAKING: $BSX secures an $11B credit package to fund the Penumbra acquisition & bolster liquidity — $3B…
BREAKING: $BSX secures an $11B credit package to fund the Penumbra acquisition & bolster liquidity — $3B revolver + $2B 364‑day revolver + $6B delayed‑draw…
8‑K filed 2/23/2026: Boston Scientific attached Exhibit 99.1 (press release dated Feb 23, 2026) and…
8‑K filed 2/23/2026: Boston Scientific attached Exhibit 99.1 (press release dated Feb 23, 2026) and Exhibit 104 (iXBRL cover page). Routine Item 9.01 filing…
On Feb 18, 2026 Boston Scientific's Board approved a $4.0B increase to its repurchase authorization,…
On Feb 18, 2026 Boston Scientific's Board approved a $4.0B increase to its repurchase authorization, bringing the program to $5.0B total (previously $1.0B).…
Boston Scientific ($BSX) appointed Ms.
Boston Scientific ($BSX) appointed Ms. Smith and Mr. Weber to its Board; press release issued Feb 23, 2026 and furnished as Exhibit 99.1 to the Form 8‑K.…
Boston Scientific ($BSX) increased its Board from 10 to 12 and appointed Catherine R.
Boston Scientific ($BSX) increased its Board from 10 to 12 and appointed Catherine R. Smith and Christophe P. Weber, effective Feb 18, 2026. Company says…
Boston Scientific ($BSX) says director Yoshiaki Fujimori told the company on Feb 2, 2026 he will not stand…
Boston Scientific ($BSX) says director Yoshiaki Fujimori told the company on Feb 2, 2026 he will not stand for re‑election at the 2026 Annual Meeting. He’s…
Boston Scientific filed an 8‑K on Feb 4, 2026 furnishing a press release (Exhibit 99.1) — press release…
Boston Scientific filed an 8‑K on Feb 4, 2026 furnishing a press release (Exhibit 99.1) — press release dated Feb 4, 2026. Investors: review the PR for any…
Boston Scientific ($BSX) issued a press release on Feb 4, 2026 announcing financial results for the fourth…
Boston Scientific ($BSX) issued a press release on Feb 4, 2026 announcing financial results for the fourth quarter and full year ended Dec 31, 2025. Release…
Boston Scientific filed an Agreement & Plan of Merger dated Jan 14, 2026 among Boston Scientific,…
Boston Scientific filed an Agreement & Plan of Merger dated Jan 14, 2026 among Boston Scientific, Pinehurst Merger Sub, Inc. and Penumbra, Inc. — Exhibit…
BREAKING: $BSX to acquire Penumbra ($PEN) — Merger Agreement filed; Penumbra will become a wholly owned…
BREAKING: $BSX to acquire Penumbra ($PEN) — Merger Agreement filed; Penumbra will become a wholly owned subsidiary. Shareholders can elect $374 cash OR…
Boston Scientific ($BSX) filed an 8‑K on Jan 15, 2026: Item 9.01 lists exhibits — a press release and…
Boston Scientific ($BSX) filed an 8‑K on Jan 15, 2026: Item 9.01 lists exhibits — a press release and investor presentation — now on EDGAR. Investors should…
Boston Scientific ($BSX) and Penumbra ($PEN) on Jan 15, 2026 executed a definitive agreement for BSX to…
Boston Scientific ($BSX) and Penumbra ($PEN) on Jan 15, 2026 executed a definitive agreement for BSX to acquire Penumbra; Pinehurst Merger Sub, Inc. is…